<DOC>
	<DOCNO>NCT01946347</DOCNO>
	<brief_summary>The aim study evaluate effect hyperinsulinemia postprandial change plasma glucose lipid concentration endothelial function together metabolic parameter patient type 2 diabetes ( T2D ) healthy subject . Hypothesis : Different change endothelial function acute vivo induce hyperinsulinemia meal test find patient T2D compare healthy subject . A significant relationship insulin sensitivity , select adipokines intramyocellular fat content , hepatic fat content high energy phosphate soleus muscle document group .</brief_summary>
	<brief_title>Endothelial Function Patients With Type 2 Diabetes Versus Healthy Subjects</brief_title>
	<detailed_description>30 patient T2D 30 healthy control subject examine outpatient basis . The following examination carry subject 12 hr fasting : - Hyperinsulinaemic euglycemic clamp study last 4 hour combine indirect calorimetry biopsy subcutaneous adipose tissue muscle aspiration biopsy - Meal test : Plasma glucose , immunoreactive insulin , plasma lipid , oxidative stress marker gastrointestinal peptide measure response standard meal ( time 0´,30´,60´,120´,180´ ) - At begin 120 minute meal test clamp peripheral microvascular endothelial function measure use EndoPat ( Itamar Medical ) - Proton phosphorus magnetic resonance spectroscopy ( MRS ) . - Dual Energy X-ray Absorptiometry ( DXA ) scan measure body composition .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<criteria>Patients T2D : Inclusion criterion 1 . Men woman age 3065 year 2 . Body Mass Index range 25 45 ( kg/m2 ) 3 . Type 2 diabetes mellitus least one year 4 . Treatment T2D : diet oral antidiabetic agent ( stable drug therapy least 3 month trial 5 . The presence metabolic syndrome three follow symptom : 1 . Abdominal obesity waist circumference men &gt; 102 cm , woman &gt; 88 cm 2 . Diagnosis treatment type 2 diabetes 3 . Raised blood pressure ( BP ) : systolic BP &gt; 130 mm Hg diastolic BP &gt; 85 mm Hg , treatment previously diagnose hypertension 4 . Reduced HDL cholesterol men &lt; 1 mmol/l , woman &lt; 1,3 mmol/l ( treatment ) 5 . Raised triglyceride &gt; 1,7 mmol/l ( treatment ) 4 . HbA1c ≥ 42 ≤100 mmol/mol Exclusion criterion 1 . Type 1 diabetes mellitus 2 . Unstable drug therapy least 3 month trial 3 . Pregnancy , breast feeding try become pregnant 4 . Alcoholism drug use 5 . Presence medical condition , occur physical examination , laboratory test , include pulmonary , neurological inflammatory disease , would consider examiner distort consistency data Healthy subject : Inclusion criterion 1 . Men woman age 3065 year 2 . Body Mass Index 2545 ( kg/m2 ) 3 . Absence metabolic syndrome two follow symptom : 1 . Abdominal obesity waist circumference men &gt; 102 cm , woman &gt; 88 cm 2 . Diagnosis treatment type 2 diabetes raise fast plasma glucose level ( FPG &gt; 5,6 mmol/l ) 3 . Raised blood pressure ( BP ) : systolic BP &gt; 130 mm Hg diastolic BP &gt; 85 mm Hg , treatment previously diagnose hypertension 4 . Reduced HDL cholesterol men &lt; 1 mmol/l , woman &lt; 1,3 mmol/l ( treatment ) 5 . Raised triglyceride &gt; 1,7 mmol/l ( treatment ) Exclusion criterion 1 . Diabetes impair glucose tolerance ( HbA1c ≥40 mmol/mol and/or FPG &gt; 5,6 mmol/l ) , diagnose diabetes firstline relatives 2 . Pregnancy , breast feeding try become pregnant 3 . Alcoholism drug use 4 . Presence medical condition , occur physical examination , laboratory test , include pulmonary , neurological inflammatory disease , would consider examiner distort consistency data</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Insulin Resistance</keyword>
	<keyword>Hyperglycemia</keyword>
	<keyword>Endothelial function</keyword>
	<keyword>Oxidative stress</keyword>
</DOC>